<h2>FYCOMPA Drug Profile, 2023</h2>

<p>This report focuses on FYCOMPA and covers the following critical aspects of this drug:</p>

<ul><li>United States patents</li>

<li>FDA Paragraph IV patent challenges</li>

<li>District Court patent litigation</li>

<li>European supplementary protection certificates (SPCs)</li>

<li>Clinical trials</li>

<li>Drug prices</li>

<li>Finished product suppliers</li>

<li>Raw active pharmaceutical ingredient (API) sources</li>

</ul>